Session: Odd Numbered Posters (The 22nd Annual Meeting of the American Society of Pediatric Hematology/Oncology)

101

Co-Transfer of Dendritic Cell Precursors to Accelerate Immune Recovery Following Hematopoietic Stem Cell Transplant
Faisal S. Razzaqi, MD, Lolie Yu, MD and Yan Cui, PhD

103

Use of Low Molecular Weight Heparin for Treatment of Veno-Occlusive Disease in Pediatric Bone Marrow Transplant Patients
John Hipps, MD MPH, Galit Rosen, MD , Kathleen M. Sakamoto, M.D., Ph.D. and Sinisa Dovat, MD DSc

105

Endocrine Function in Young Children with Malignant Brain Tumors Treated with Marrow Ablative Chemotherapy and Avoidance of Irradiation: The Childrens Hospital Los Angeles (CHLA) Experience, 1991-2008
Ruby A. Hiramanek, B.A., Liora Pollick, Jaimin Amin, B.S., Araz Marachelian, M.D., Anna Butturini, M.D., David R. Freyer, D.O., M.S. and Jonathan L. Finlay, M.B., Ch.B.

107

Increased Treatment Related MORTALITY in Adolescents and Young Adults Following Bone Marrow Transplant
Chu Ri Shin, MD, Thuan Nguyen, MD, PhD and Eneida R. Nemecek, MD

109

Interrater Comparisons of Children's Health-Related Quality of Life(HRQL) during the Acute Peri-Transplant Period
Arun R. Panigrahi, M.D., Sara J. Ratichek, MA, Christopher Recklitis, PhD, MPH, Grace Chang, MD, MPH, Hocine Tighiouart, MS, Norma Terrin, PhD and Susan K. Parsons, MD, MRP

111

Parental Stressors and Coping in Pediatric Hematopoietic Stem Cell Transplant (HSCT)
Emily K. Carr, MD, MPH, Sara J. Ratichek, MA, Mary Jo Kupst, PhD, Kristin Bingen, PhD, Christopher Recklitis, PhD, MPH, Grace Chang, MD, MPH, Hocine Tighiouart, MS, Norma Terrin, PhD and Susan K. Parsons, MD, MRP

113

Patterns of Academic Achievement in Children with Sickle Cell Disease
Amanda S. Epping, MA, Robert F. Newby, PhD, Julie A. Panepinto, MD, MSPH, Amanda M. Brandow, DO, MS, Danielle L. Jirovec, BA and J. Paul Scott, MD

115

In Situ Phenotypic Characterization of the Mesenchymal Blanket Cell in the Stem Cell Niche
Sarah Vaiselbuh, MD, Jeffrey M. Lipton, MD-PhD, Bruce Seideman, MD and Johnson M. Liu, MD

117

Erythrocytapheresis Is Effective in Reducing Serum Ferritin among Children with Sickle Cell Disease, but Impact on Total Body Iron Is Uncertain
Anthony N. Audino, MD, Carol Shaw, RN and Jeffrey Hord, MD

119

A Retrospective Review of the Etiologies of Pancytopenia in Hospitalized Children without Cancer
Meghann Pine, DO, MPH

121

Therapeutic Factors and Outcome in Ewing's Sarcoma (EWS) at Pediatric (PI) Vs. Adult Institution (AI)
Abha Gupta, Alberto Pappo, Natasha Saunders, Uri Edell, Rupinder Chera, Derek Stephens, Lillian Sung, Paul Babyn, Anthony Griffin, Mark L. Greenberg and Martin Blackstein

123

Asymptomatic Child Heterozygous for Hemoglobin S and Hemoglobin Porto Alegre
Liliana Lojo-Welburn, MD, Pedro J. Santiago-Borrero, MD, Enid Rivera, MD, Doris Rivera, MT, Jessicca Renta, MS and Carmen L. Cadilla, PhD

125

Natural Killer and T-Natural Killer Cell Frequency in Individuals Born in and Outside the United States: a Descriptive Study
Ibrahim Ahmed, M.D., D.Sc., Steven A. Buck, PhD, Yaddanapudi Ravindranath, MBBS, Ronald L. Thomas and Sureyya Savasan, M.D.

127

Coagulation Laboratory Screening Is Not a Good Predictor for Bleeding Complications in Pediatric Patients Requiring Peripherally Inserted Central Catheters
Joel Woodley-Cook, MSc, Joao Amaral, MD, Bairbre Connolly, MB, BCh, BAO and Leonardo Brandao, MD

129

Human 14-3-3β Expression Is up-Regulated during Megakaryocytic Differentiation
Chutima Kumkhaek, Ph.D, Wenli Liu, MD, Wulin Aerbajinai, MD, PhD, Jianqiong Zhu, MD, Suthat Fucharoen, MD and Griffin Rodgers, MD, MACP

131

Warfarin Pharmacogenetics in Children: Knowledge and Attitudes
Courtney D. Thornburg, MD, MS, Emma Jones, MD, Lisa Bomgaars, MD and Brian Gage, MD, MSc

133

Analysis from the Hemophilia and Thrombosis Research Society (HTRS) Registry of Bleeding Patterns in Frequently-Bleeding Congenital Hemophilia Patients with Inhibitors
Ellis J. Neufeld, MD, PhD and David L. Cooper, MD, MBA

135

Seroprevalence of PF4/Heparin Antibodies among Blood Bank Donors
Poulomi J. Pai, MD, Julianna E. McCracken and Gowthami M. Arepally, MD

137

Development of a Pediatric Quality of Life Inventory for Children Requiring Long-Term Anticoagulation
Aisha AK Bruce, M.D., FRCPC, Mary E. Bauman, RN, BA, NP, MN, Amanda Newton, PhD, Michelle Bauman, Laszlo Bajzar, PhD, Karina Black, RN, BScN, NP, MN and M. Patricia Massicotte, MD, MHSc, FRCPC,

139

Thrombin Generation in Children with Hemophilia
Shilpa Jain, MD, MPH and Meera Chitlur, M.D.

141

Ornithine Transcarbamylase Deficiency: a Possible Risk Factor for Thrombosis
Lakshmi Venkateswaran, MD, Fernando Scaglia, MD, Valerie McLin, MD, Paula Hertel, MD, Oleg Shchelochkov, MD, Saul Karpen, MD, PhD, Donald Mahoney Jr, MD and Donald L. Yee, M.D., M.S.

143

Lupus Anticoagulant Hypoprothrombinemia Syndrome (LAHPS)
Mona D. Shah, MD, Ankur A. Kamdar, MD, Jun Teruya, MD, DSc, Barry L. Myones, MD and Ching C. Lau, MD, PhD

145

Effective and Safe Acute Tumor Lysis Syndrome (ATLS) Prophylaxis with Rasburicase and Non-Alkaline Hydration in Children and Adolescents with Advanced Stage III/IV Intermediate Risk B-Cell Non-Hodgkin Lymphoma (B-NHL): a Children's Oncology Group Report
Stanton Goldman, MD, James Lynch, PhD, Lauren Harrison, RN and Mitchell S. Cairo

147

A Robust Xenotransplantation Model of Acute Myeloid Leukemia
Robin L. Perry, MD, Patricia V. Sanchez, PHD, Jean-Emmanuel Sarry, PHD, Kathleen Murphy, BA, Alexander Perl, MD, Adam Bagg, MDu, Vivianna van Deerlin, Jacklyn Biegel, MD, Gwenn-ael Danet-Desnoyers, PhD and Martin Carroll, MD

149

Identification of Novel Biomarkers in T-Cell Malignancies
Jason Law, MD

151

Mechanisms of CALM-Dependent Leukemogenesis: CALM Fusion Proteins Upregulate Expression of the IL-3 Growth Factor Receptor
Jennifer A. Walker, MD, Daniel S. Wechsler, MD, PhD and Catherine P. Lavau, DVM, PhD

153

Preferences and Knowledge Gaps Among Pediatric Oncologists Regarding the Care of Childhood Cancer Survivors: A Survey of Nearly 1200 Physicians
Tara Henderson, MD, MPH, Lisa Diller, MD, Fay Hlubocky, Suzanne Arata and Christopher Daugherty, MD

155

Predictors of Osteopenia/Osteoporosis in Children with Acute Lymphoblastic Leukemia
Uma Athale, MD, Collin Webber, MD and Ronald D. Barr

157

Langerhans Cell Histiocytosis in Infants Less Than One Year: a Single Center Experience
Lina Jaramillo, MD, Adriana Linares, Maria Paula Aristizabal, Pediatric Hemato, Fabio Restrepo and Isabel Sarmiento, MD

159

Prevalence and Clinical Characterization of CD20 and CD22 Expression in Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia
Melissa S. Rayburg, MD, Daniel Marmer, Jun Mo, MD, Richard McMasters, MD, Teresa Smolarek, Beatrice Lampkin, MD and John Perentesis, MD

161

Predictors of Outcome and Microbiology of Episodes of Febrile Neutropenia among Children with Cancer in El Salvador, a Low-Income Country
Sumit Gupta, MD, Miguel Bonilla, MD, Mario Gamero, MD, Jaime Jerez, MD, Miguela Caniza, MD, Scott C. Howard, MD, MS, Ronald Barr, MD, Raul Ribeiro, MD and Lillian Sung, MD, PhD

163

An Assessment of the Current State of Palliative Care Education in Pediatric Hematology/ Oncology Fellowship Training
Michael Roth, MD, Mimi Kim, Sc.D. and Karen Moody, MD

165

Lung Involvement in CHILDREN with Langerhans CELL Histiocytosis
Adriana Linares, Maria Paula Aristizabal, MD, Lina Jaramillo, MD, Luz Angela Moreno, MD, Fabio Restrepo, MD, Mauricio Cortes, MD, Silverio Casta�o, MD, Eduardo Beltran, MD, Isabel Sarmiento, MD, Ruben Montoya, Liliana Henao, MD and Susana Murcia, MD

167

Progressive Transformation of Germinal Centers in Children: An Intriguing Picture
Furqan Shaikh, Bo-Yee Ngan, Sarah Alexander and Ronald M. Grant

169

The Effect on Sleep by Dexamethasone Extends beyond the Days of Therapy for up to 10 Days, in Children during Maintenance Therapy for ALL
Gerald Rosen, MD, Marsha Finkelstein, MS, Meixia Liu, MS, Anne Harris, BA and Yoav Messinger, MD

171

Assessment of Paediatric Haematology/Oncology Fellows' Training in the Performance of Lumbar Punctures
Alexandra Airhart, John Doyle, MD, Constance Airhart, RN, Oussama Abla, MD and Sarah Alexander, MD

173

Weekend Delay in Intiation of Chemotherapy for Acute Lymphoblastic Leukemia (ALL) - Does It Matter?
Shannon Wahl, M.D., Shanda Robertson, B.S., Lynne Neumayr, M.D. and James Feusner, M.D.

175

Nutritional State of the Patient with Leukemia at the Hospital Infantil De Morelia Part I: The Effect of the Leukemia on the Nutritional State
Esteban Lopez, MD, Carolina Torres, CNS, Katia J. Juanchi, CNS, Gloria Bedolla, CNS, Irma P. Rivera, CNS, Eliza Y. Pinera, CNS, Zhenia D. Pe�aloza, CNS, Silvia Chavez, MD and Primo Cruz, MD

177

Iron Resistant Iron Deficiency Anemia: Long Term Follow-up of 5 Patients
Kip R. Hartman, MD, Karin E. Finberg and Margret E. Merino, MD

179

Clinical Events after Splenectomy in Children with Sickle Cell Anemia
Ian Kane, BS, Ibrahim Shatat, MD, MSCR, Elizabeth Rackoff, RN, Deborah Disco, RN, MS, PNP, Sherron Jackson, MD and Ram Kalpatthi, MD

181

Hydroxyurea Is Effective in Preventing Reoccurrence of Acute Chest Syndrome in Children with Sickle Cell Anemia
Caterina P. Minniti, MD, Ana Burgos, MD, Victor Gordeuk, MD and Barbara speller-Brown, PNP

183

Low Prevalence of Pulmonary Artery Hypertension in Children with Sickle Cell Anemia
Ram Kalpatthi, MD, Alexander Ngwube, MD, Anthony Hlavacek, Michael Bowman, Sherron Jackson and Hamayun Imran, MD, MSc

185

Hydroxyurea Therapy Increases Expression of BCAM/LU in Children with Sickle Cell Disease
Clarissa Johnson, MD and Marilyn Telen, MD

187

Dietary Effects of Nitrates and Nitrites on Sickle Cell Disease Severity in Children
Ramsay A. Singer, BA, MBBS, Diana Cardona-Grau, BA, Deidre Dexter, RD and Philippa Sprinz, MD

189

Acute Management of Vaso-Occlusive Pain in Pediatric Sickle Cell Disease
Jennifer Freed, M.D. and Katherine L. Ender, M.D.

191

TRKB in Neuroblastoma: Following Pathways to Better Therapies
Timothy C. Graham, BS, Lizhi Zeng, MD, Alejandro G. Levy, MD, Maurizio L. Ghisoli, MD, Sankaranarayanan Kannan, PhD, Riitta Nolo, PhD, Wendy Fang, MD, Peter E. Zage, MD/PhD and Patrick A. Zweidler-McKay, MD/PhD

193

Inhibition of Aurora Kinase A Suppresses Medulloblastoma Cell Growth
Ayman A. El-sheikh, MD, Rong Fan, RA, Diane Birks, RA, Andrew Donson, BS.c, Nicholas Foreman, MBChB and Rajeev Vibhakar, MD

195

Outcome of Patients with Recurrent Central Nervous System Germ Cell Tumors: a Retrospective Study, 2003-2008
Rebecca L. Stahl, M.D., Jaimin Amin, B.S., Sharon Gardner, M.D., Jeffrey Allen, M.D. and Jonathan Finlay, M.B., Ch.B.

197

Phase I Study of the Combination of Anti-GD2 Antibody 3F8 and Yeast-Derived (1→3), (1→ 6)-b-D-Glucan for Resistant Neuroblastoma
Shakeel Modak, MD, MRCP, Brian Kushner, MD, Kim Kramer, MD and Nai-Kong Cheung, MD, PhD

199

Outpatient Osteosarcoma Chemotherapy in Adolescents and Young Adults: High Patient Acceptance
Vivek Subbiah, MD, Chetan Anil Dhamne, MD , Paula Garroutte and Pete Anderson, MD, PhD

201

Inhibition of IGF-I Receptor Signaling in Combination with Rapamycin or Temsirolimus Increases MYC-N Phosphorylation
Don W. Coulter, MD, Mary Beth Wilkie and Billie M. Moats-Staats, PhD

203

Dual Targeting of AMD1 and ODC1 Potently Inhibits Neuroblastoma Initiation in the TH-Mycn Mouse MODEL
Nicholas Evageliou, MD, Annette Vu, Xueyuan Liu, Rosalind Barr, Candace Hayes, Murray Norris, MD, Glenn Marshall, Michele Haber, MD, Susan Gilmour, PhD and Michael Hogarty, MD

205

Efficacy of High Dose Chemotherapy and Autologous Stem Cell Transplant for Recurrent Wilms' Tumor: a Meta Analysis
Angela Presson, PhD, Theodore Moore, MD and Pamela Kempert, M.D

207

Association of High Ceramide Levels with Unfavorable Neuroblastoma Risk Factors: a Report from the Children's Oncology Group
Heather Escoto, MD, Wendy B. London, PhD, Patrick W. McGrady, MS and Jacqueline M. Kraveka, DO

209

Human Rhabdomyosarcoma Cell Lines Contain Myogenically Primitive CD133+ Cells That Are Sensitive to Killing by Engineered Herpes Simplex Virus
Gregory K. Friedman, MD, G. Yancey Gillespie, PhD and Joseph G. Pressey, MD

211

Pilot Study of Proactive Enteral Tube Feedings in Children with High Risk Tumors
Nancy Sacks, MS, RD, LDN, John Pietsch, MD, Eric Sandler, MD, Paul C. Rogers, MB ChB, Beth Wallace, RD, LDN and Susan R. Rheingold, MD

213

Ethnic and Racial Differences in Patients with Ewing Sarcoma
Jennifer Worch, MD, Katherine Matthay, MD, Robert Goldsby, MD and Steven DuBois, MD

215

L-MTP-PE (MEPACT) for Osteosarcoma: Current Status and Compassionate Access Program
Chetan Anil Dhamne, MD , Pete Anderson, MD, PhD, Paul A. Meyers, M.D., Vivek Subbiah, MD, Dennis Hughes, MD, PhD, Kathleen Cornelius, Lori Bloodworth and Eugenie Kleinerman, MD

217

Analysis of Gluthamine Synthetase Expression in Hepatoblastoma
Steven W. Warmann, Andreas Schmidt, Guido Seitz, Michael Schwarz and Joerg Fuchs

219

Pleomorphic Xanthoastrocytoma: a Single Institutional Experience and Review of Literature
Amulya A. Nageswara Rao, MD, Cynthia J. Wetmore, MD, PhD and Nadia N. Laack, MD

221

Recognition and Treatment of Fatigue in Children with Advanced Cancer
Christina Ullrich, MD, MPH, Veronica Dussel, MD, MPH, Joanne M. Hilden, MD, Jan Sheaffer, Caron Moore, MSW, RN, CPON, Charles Berde, MD, PhD and Joanne Wolfe, MD, MPH

223

Radiation Induced Pulmonary Injury in Survivors Following Whole Lung Irradiation for a Childhood Malignancy
Martha M. Stegner, MD, Peter Luckett, MD, John Fitzgerald, MD, Cindy Cochran, RN, MSN, CPNP, Debra Kent, RN, MSN, CPNP and Patrick J. Leavey, MD

225

Prognostic Significance of Early Lymphocyte Recovery in Pediatric Osteosarcoma
Robert Sutphin, M.D. and Colin Moore, M.D.

227

Effectiviness of Aprepitant, Dolasetron and Dexamethasone for the Prevention of Vomiting Caused by High Doses of Cisplatin in Patients with Osteosarcoma
Esteban Lopez, MD, Silvia Chavez, MD and Primo Cruz, MD

229

Sorafenib in Alveolar Rhabdomyosarcoma
Ying Xuan Chua, Aoife Kilcoyne, MB BCh BAO, Jinu Abraham, Eri Taniguchi, Suresh Prajapati, Laura Hampton and Charles Keller

231

Treatment of High-Risk Vascular Lesions with Systemic Chemotherapy
Albert S. Cornelius, MD, Lauren A. Nicholls, MD and Andrea J. Pearson, BS

233

Treatment Late Effects of High Risk Neuroblastoma
Laurie E. Cohen, MD, Samantha C. Gunawardene, CPNP, Eileen Duffey-Lind, CPNP, Suzanne Shusterman, MD, Leslie E. Lehmann, MD and Lisa Diller, MD

235

Quality of Life as Parameters of Quality Control in Oncology Care: Evaluation by the M�nster/Heidelberg (FMH) Index
Vivek Subbiah, MD, Marion Pilz, Ove Peters and Johannes Wolff, MD

237

Secondary Renal Carcinoma in Survivors of Childhood Wilms Tumor
Lisa Kopp, D.O., Romina Sabella-River, M.D., Alejandro G. Levy, Winston Huh, Angela H. Xu and Joann L. Ater